查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1810911

2025年全球基因檢測市場報告

Hereditary Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年基因檢測市場將強勁成長，2029年將達到93.5億美元，複合年成長率為9.0%。預測期內的成長可歸因於公共和私人基因組學舉措之間合作的加強、對無創產前檢測 (NIPT) 的需求不斷成長、基因檢測組合和套件類型的不斷增加、其在全民篩檢項目中的應用日益廣泛，以及對預防性和精準公共衛生的日益重視。這段時期的主要趨勢包括新一代定序 (NGS) 的進步、NIPT 的創新、生物資訊學平台的進步、照護現場基因檢測儀器的改進以及多基因組合檢測的發展。

遺傳病患病率的上升預計將推動未來基因檢測市場的成長。遺傳疾病是由個體去氧核糖核酸(DNA) 異常或突變引起的疾病，可從父母一方或雙方遺傳，或自然發生。遺傳病患病率的上升部分是由於父母老化，這增加了將基因突變遺傳給後代的可能性。基因檢測可幫助遺傳疾病患者識別遺傳突變、實現早期診斷、指導個人化治療並協助計劃生育決策。例如，2024 年 10 月，英國慈善機構囊性纖維化信託基金報告稱，註冊的囊腫纖維化患者人數從 2022 年的 11,148 人增加到 2023 年的 11,318 人。因此，遺傳病患病率的上升正在推動基因檢測市場的發展。

基因檢測市場的主要企業正專注於基因檢測套組的技術進步，以提高準確性、縮短週轉時間並擴大對更廣泛基因突變的檢測。基因檢測套組是一種診斷工具，旨在分析個體的 DNA，以識別與遺傳性疾病和風險因素相關的突變或變異。例如，2023 年 7 月，專門生產遺傳性疾病 DNA 診斷套件的瑞典生物技術公司 Devyser Diagnostics AB 推出了兩款新的標靶下一代定序試劑套件：Devyser LynchFAP 和 Devyser BRCA PALB2。 Devyser LynchFAP 能夠全面分析 PMS2（解決假基因 PMS2CL 帶來的挑戰）和其他九個與遺傳性大腸直腸癌症候群相關的關鍵基因。 Devyser BRCA PALB2 是一種簡化的單管解決方案，用於篩檢血液和腫瘤樣本中的 BRCA1、BRCA2 和 PALB2 突變。它旨在透過易於使用的測序和專用軟體支援高效的實驗室工作流程，以可靠地檢測遺傳性癌症風險。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球基因檢測：PESTEL分析（政治、社會、科技、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球基因檢測市場：成長率分析
  • 全球基因檢測市場表現：規模與成長，2019-2024
  • 全球基因檢測市場預測：規模與成長，2024-2029，2034
  • 全球基因檢測：總目標市場（TAM）

第6章 市場細分

  • 全球基因檢測市場（按檢測類型、效能和預測），2019-2024 年、2024-2029 年、2034 年
  • 預測測試
  • 攜帶者檢測
  • 產前檢查
  • 新生兒篩檢
  • 診斷測試
  • 其他
  • 全球基因檢測市場（依樣本類型）：績效與預測，2019-2024 年、2024-2029 年、2034 年
  • 血液樣本
  • 唾液樣本
  • 組織樣本
  • 口腔拭子
  • 尿液樣本
  • 全球基因檢測市場（依所用技術、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 下一代定序（NGS）
  • 聚合酵素鏈鎖反應（PCR）
  • 桑格定序
  • 微陣列技術
  • 全基因組定序（WGS）
  • 全球基因檢測市場的應用、表現及預測（2019-2024、2024-2029、2034）
  • 腫瘤學
  • 心血管疾病
  • 神經系統疾病
  • 代謝紊亂
  • 其他
  • 全球基因檢測市場（按最終用戶、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 診斷實驗室
  • 研究所
  • 製藥公司
  • 病人和消費者
  • 全球基因檢測市場：預測性測試細分，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 1 型乳癌(BRCA1) 和第 2 型乳癌(BRCA2) 基因突變檢測
  • 林奇症候群檢測
  • 遺傳性高膽固醇症血症檢測
  • 亨丁頓舞蹈症檢測
  • 心肌病基因檢測
  • 全球基因檢測市場：載體檢測細分，按類型、績效和預測，2019-2024 年、2024-2029 年、2034 年
  • 囊腫纖維化帶因者篩檢
  • 戴-薩克斯病帶因者篩檢
  • 脊髓性肌肉萎縮症 (SMA) 帶因者篩檢
  • 地中海貧血帶因者篩檢
  • 鐮狀細胞帶因者檢測
  • 全球基因檢測市場：產前檢測細分市場，依類型、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 非侵入性產前檢測（NIPT）
  • 絨毛膜絨毛採樣（CVS）
  • 羊膜穿刺術
  • 擴大帶因者篩檢（產前）
  • 免費胎兒去氧核糖核酸檢測
  • 全球基因檢測市場：新生兒篩檢細分市場、類型、績效及預測（2019-2024、2024-2029、2034）
  • 苯酮尿症（PKU）篩檢
  • 先天性甲狀腺機能低下症篩檢
  • 囊腫纖維化篩檢
  • 鐮狀細胞疾病篩檢
  • 聽力損失和代謝紊亂小組
  • 全球基因檢測市場：診斷測試細分，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 罕見疾病基因檢測
  • 遺傳性癌症診斷測試
  • 心臟發育診斷小組
  • 神經遺傳疾病檢測
  • 單基因疾病檢測組
  • 全球基因檢測市場：其他細分市場、按類型、實際結果和預測，2019-2024 年、2024-2029 年、2034 年
  • 藥物基因組學檢測
  • 胚胎胚胎著床前遺傳學診斷（PGD）
  • 全EXOME定序（WES）
  • 全基因組定序（WGS）
  • 粒線體去氧核糖核酸檢測

第7章 區域和國家分析

  • 全球基因檢測市場：2019-2024 年、2024-2029 年和 2034 年區域表現和預測
  • 全球基因檢測市場：國家、績效及預測（2019-2024、2024-2029、2034）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 基因檢測市場：競爭格局
  • 基因檢測市場：公司簡介
    • F. Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific Inc.
    • Laboratory Corporation of America Holdings
    • Quest Diagnostics Incorporated
    • Agilent Technologies Inc.

第31章：其他領先和創新企業

  • Illumina Inc.
  • CooperSurgical Inc.
  • QIAGEN NV
  • Natera Inc.
  • Myriad Genetics Inc.
  • Fulgent Genetics Inc
  • Invitae Corporation
  • GeneDx LLC
  • Twist Bioscience Corporation
  • Color Health Inc.
  • MedGenome Inc
  • SOPHiA GENETICS SA
  • Gene By Gene Ltd.
  • Dante Labs Inc.
  • 23mofang Co. Ltd.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

  • 2029 年基因檢測市場：提供新機會的國家
  • 2029 年基因檢測市場：細分領域帶來新機會
  • 2029年基因檢測市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r37011

Hereditary testing, also known as genetic testing for inherited conditions, involves analyzing an individual's DNA to detect genetic mutations or variations inherited from their parents. These tests help evaluate the risk of developing or passing on inherited diseases, assist in diagnosing genetic disorders, and support personalized treatment or preventive care decisions.

The primary types of hereditary testing include predictive testing, carrier testing, prenatal testing, newborn screening, diagnostic testing, and others. Predictive testing is used to determine the likelihood that an individual will develop a particular disease or condition in the future, before symptoms arise. Sample types for these tests include blood, saliva, tissue, buccal swabs, and urine. The technologies employed range from next-generation sequencing (NGS), polymerase chain reaction (PCR), Sanger sequencing, microarray technology, to whole genome sequencing (WGS). These tests are applied in various fields such as oncology, cardiovascular diseases, neurological disorders, metabolic disorders, and more, and are utilized by a wide range of end users including hospitals, diagnostic labs, research institutions, pharmaceutical companies, patients, and consumers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The hereditary testing market research report is one of a series of new reports from The Business Research Company that provides hereditary testing market statistics, including hereditary testing industry global market size, regional shares, competitors with a hereditary testing market share, detailed hereditary testing market segments, market trends and opportunities, and any further data you may need to thrive in the hereditary testing industry. The hereditary testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hereditary testing market size has grown strongly in recent years. It will grow from $6.05 billion in 2024 to $6.62 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. The growth during the historic period can be credited to increasing parental age, broader use in cancer risk assessment, heightened demand for early diagnosis and prevention, a rising burden of rare and chronic diseases, improved access to genetic counseling services, and greater adoption of hereditary testing in reproductive health.

The hereditary testing market size is expected to see strong growth in the next few years. It will grow to $9.35 billion in 2029 at a compound annual growth rate (CAGR) of 9.0%. The anticipated growth in the forecast period can be attributed to expanding collaborations between public and private genomic initiatives, rising demand for non-invasive prenatal testing (NIPT), an increasing variety of genetic testing panels and kits, greater use in population-wide screening programs, and a stronger focus on preventive and precision public health. Key trends during this period include advancements in next-generation sequencing (NGS), technological innovations in NIPT, progress in bioinformatics platforms, improvements in point-of-care genetic testing devices, and developments in multi-gene panel testing.

The rising prevalence of genetic disorders is expected to drive the growth of the hereditary testing market in the future. Genetic disorders are medical conditions caused by abnormalities or mutations in an individual's deoxyribonucleic acid (DNA), inherited from one or both parents or occurring spontaneously. The increase in genetic disorders is partly due to higher parental age, which raises the chances of passing genetic mutations to offspring. Hereditary testing aids patients with genetic disorders by enabling early diagnosis, guiding personalized treatments, and assisting family planning decisions through the identification of inherited mutations. For example, in October 2024, the Cystic Fibrosis Trust, a UK-based charity, reported that the number of registered cystic fibrosis patients increased to 11,318 in 2023, up from 11,148 in 2022. Thus, the growing prevalence of genetic disorders is fueling the hereditary testing market.

Key players in the hereditary testing market are focusing on technological advancements in genetic test kits to improve accuracy, shorten turnaround times, and expand the detection of a wider range of genetic mutations. Genetic test kits are diagnostic tools designed to analyze an individual's DNA to identify mutations or variations linked to inherited diseases or risk factors. For instance, in July 2023, Devyser Diagnostics AB, a Sweden-based biotech company specializing in DNA diagnostic kits for hereditary diseases, launched two new targeted next-generation sequencing kits: Devyser LynchFAP and Devyser BRCA PALB2. Devyser LynchFAP allows comprehensive analysis of PMS2 (addressing challenges from its pseudogene PMS2CL) along with nine other key genes associated with hereditary colorectal cancer syndromes. Devyser BRCA PALB2 provides a streamlined single-tube solution for screening BRCA1, BRCA2, and PALB2 mutations in both blood and tumor samples, designed to support efficient lab workflows with user-friendly sequencing and dedicated software for confident detection of hereditary cancer risks.

In May 2025, GeneDx LLC, a US-based biotechnology firm specializing in genetic testing, acquired Fabric Genomics for an undisclosed sum. This acquisition aims to enhance GeneDx's genomic interpretation capabilities by integrating Fabric Genomics' AI-powered platform, thereby strengthening its hereditary disease diagnostic offerings and enabling faster, more scalable genetic analysis. Fabric Genomics is a US-based computational genomics company providing hereditary testing solutions.

Major players in the hereditary testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., CooperSurgical Inc., QIAGEN N.V, Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc, Invitae Corporation, GeneDx LLC, Twist Bioscience Corporation, Color Health Inc., MedGenome Inc, SOPHiA GENETICS SA, Gene By Gene Ltd., Dante Labs Inc., 23mofang Co. Ltd.

North America was the largest region in the hereditary testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in hereditary testing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the hereditary testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hereditary testing market includes revenues earned by entities through services such as genetic screening, pharmacogenetic testing, and presymptomatic testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hereditary Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hereditary testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hereditary testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hereditary testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Test Type: Predictive Testing; Carrier Testing; Prenatal Testing; Newborn Screening; Diagnostic Testing; Other Test Types
  • 2) By Sample Type: Blood Samples; Saliva Samples; Tissue Samples; Buccal Swabs; Urine Samples
  • 3) By Technology Used: Next-Generation Sequencing (NGS); Polymerase Chain Reaction (PCR); Sanger Sequencing; Microarray Technology; Whole Genome Sequencing (WGS)
  • 4) By Application: Oncology; Cardiovascular Diseases; Neurological Disorders; Metabolic Disorders; Other Applications
  • 5) By End User: Hospitals; Diagnostic Laboratories; Research Institutes; Pharmaceutical Companies; Patients And Consumers
  • Subsegments:
  • 1) By Predictive Testing: Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Gene Mutation Testing; Lynch Syndrome Testing; Familial Hypercholesterolemia Testing; Huntington's Disease Testing; Cardiomyopathy Genetic Testing
  • 2) By Carrier Testing: Cystic Fibrosis Carrier Screening; Tay-Sachs Carrier Screening; Spinal Muscular Atrophy (SMA) Carrier Screening; Thalassemia Carrier Screening; Sickle Cell Carrier Testing
  • 3) By Prenatal Testing: Non-Invasive Prenatal Testing (NIPT); Chorionic Villus Sampling (CVS); Amniocentesis; Expanded Carrier Screening (Prenatal Context); Cell-Free Fetal Deoxyribonucleic Acid Testing
  • 4) By Newborn Screening: Phenylketonuria (PKU) Screening; Congenital Hypothyroidism Screening; Cystic Fibrosis Screening; Sickle Cell Disease Screening; Hearing Loss and Metabolic Disorder Panels
  • 5) By Diagnostic Testing: Rare Disease Genetic Testing; Inherited Cancer Diagnostic Testing; Cardiogenetic Diagnostic Panels; Neurogenetic Disorder Testing; Monogenic Disease Panels
  • 6) By Other Test Types: Pharmacogenomics Testing; Preimplantation Genetic Diagnosis (PGD); Whole Exome Sequencing (WES); Whole Genome Sequencing (WGS); Mitochondrial Deoxyribonucleic Acid Testing
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Laboratory Corporation of America Holdings; Quest Diagnostics Incorporated; Agilent Technologies Inc.; Illumina Inc.; CooperSurgical Inc.; QIAGEN N.V; Natera Inc.; Myriad Genetics Inc.; Fulgent Genetics Inc; Invitae Corporation; GeneDx LLC; Twist Bioscience Corporation; Color Health Inc.; MedGenome Inc; SOPHiA GENETICS SA; Gene By Gene Ltd.; Dante Labs Inc.; 23mofang Co. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hereditary Testing Market Characteristics

3. Hereditary Testing Market Trends And Strategies

4. Hereditary Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Hereditary Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Hereditary Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Hereditary Testing Market Growth Rate Analysis
  • 5.4. Global Hereditary Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Hereditary Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Hereditary Testing Total Addressable Market (TAM)

6. Hereditary Testing Market Segmentation

  • 6.1. Global Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Predictive Testing
  • Carrier Testing
  • Prenatal Testing
  • Newborn Screening
  • Diagnostic Testing
  • Other Test Types
  • 6.2. Global Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Samples
  • Saliva Samples
  • Tissue Samples
  • Buccal Swabs
  • Urine Samples
  • 6.3. Global Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Sanger Sequencing
  • Microarray Technology
  • Whole Genome Sequencing (WGS)
  • 6.4. Global Hereditary Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oncology
  • Cardiovascular Diseases
  • Neurological Disorders
  • Metabolic Disorders
  • Other Applications
  • 6.5. Global Hereditary Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Diagnostic Laboratories
  • Research Institutes
  • Pharmaceutical Companies
  • Patients And Consumers
  • 6.6. Global Hereditary Testing Market, Sub-Segmentation Of Predictive Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Breast Cancer 1 (BRCA1) And Breast Cancer 2 (BRCA2) Gene Mutation Testing
  • Lynch Syndrome Testing
  • Familial Hypercholesterolemia Testing
  • Huntington's Disease Testing
  • Cardiomyopathy Genetic Testing
  • 6.7. Global Hereditary Testing Market, Sub-Segmentation Of Carrier Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cystic Fibrosis Carrier Screening
  • Tay-Sachs Carrier Screening
  • Spinal Muscular Atrophy (SMA) Carrier Screening
  • Thalassemia Carrier Screening
  • Sickle Cell Carrier Testing
  • 6.8. Global Hereditary Testing Market, Sub-Segmentation Of Prenatal Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Non-Invasive Prenatal Testing (NIPT)
  • Chorionic Villus Sampling (CVS)
  • Amniocentesis
  • Expanded Carrier Screening (Prenatal Context)
  • Cell-Free Fetal Deoxyribonucleic Acid Testing
  • 6.9. Global Hereditary Testing Market, Sub-Segmentation Of Newborn Screening, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Phenylketonuria (PKU) Screening
  • Congenital Hypothyroidism Screening
  • Cystic Fibrosis Screening
  • Sickle Cell Disease Screening
  • Hearing Loss And Metabolic Disorder Panels
  • 6.10. Global Hereditary Testing Market, Sub-Segmentation Of Diagnostic Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Rare Disease Genetic Testing
  • Inherited Cancer Diagnostic Testing
  • Cardiogenetic Diagnostic Panels
  • Neurogenetic Disorder Testing
  • Monogenic Disease Panels
  • 6.11. Global Hereditary Testing Market, Sub-Segmentation Of Other Test Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmacogenomics Testing
  • Preimplantation Genetic Diagnosis (PGD)
  • Whole Exome Sequencing (WES)
  • Whole Genome Sequencing (WGS)
  • Mitochondrial Deoxyribonucleic Acid Testing

7. Hereditary Testing Market Regional And Country Analysis

  • 7.1. Global Hereditary Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Hereditary Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hereditary Testing Market

  • 8.1. Asia-Pacific Hereditary Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hereditary Testing Market

  • 9.1. China Hereditary Testing Market Overview
  • 9.2. China Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hereditary Testing Market

  • 10.1. India Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hereditary Testing Market

  • 11.1. Japan Hereditary Testing Market Overview
  • 11.2. Japan Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hereditary Testing Market

  • 12.1. Australia Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hereditary Testing Market

  • 13.1. Indonesia Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hereditary Testing Market

  • 14.1. South Korea Hereditary Testing Market Overview
  • 14.2. South Korea Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hereditary Testing Market

  • 15.1. Western Europe Hereditary Testing Market Overview
  • 15.2. Western Europe Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hereditary Testing Market

  • 16.1. UK Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hereditary Testing Market

  • 17.1. Germany Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hereditary Testing Market

  • 18.1. France Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hereditary Testing Market

  • 19.1. Italy Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hereditary Testing Market

  • 20.1. Spain Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hereditary Testing Market

  • 21.1. Eastern Europe Hereditary Testing Market Overview
  • 21.2. Eastern Europe Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hereditary Testing Market

  • 22.1. Russia Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hereditary Testing Market

  • 23.1. North America Hereditary Testing Market Overview
  • 23.2. North America Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hereditary Testing Market

  • 24.1. USA Hereditary Testing Market Overview
  • 24.2. USA Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hereditary Testing Market

  • 25.1. Canada Hereditary Testing Market Overview
  • 25.2. Canada Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hereditary Testing Market

  • 26.1. South America Hereditary Testing Market Overview
  • 26.2. South America Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hereditary Testing Market

  • 27.1. Brazil Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hereditary Testing Market

  • 28.1. Middle East Hereditary Testing Market Overview
  • 28.2. Middle East Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hereditary Testing Market

  • 29.1. Africa Hereditary Testing Market Overview
  • 29.2. Africa Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hereditary Testing Market Competitive Landscape And Company Profiles

  • 30.1. Hereditary Testing Market Competitive Landscape
  • 30.2. Hereditary Testing Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Hereditary Testing Market Other Major And Innovative Companies

  • 31.1. Illumina Inc.
  • 31.2. CooperSurgical Inc.
  • 31.3. QIAGEN N.V
  • 31.4. Natera Inc.
  • 31.5. Myriad Genetics Inc.
  • 31.6. Fulgent Genetics Inc
  • 31.7. Invitae Corporation
  • 31.8. GeneDx LLC
  • 31.9. Twist Bioscience Corporation
  • 31.10. Color Health Inc.
  • 31.11. MedGenome Inc
  • 31.12. SOPHiA GENETICS SA
  • 31.13. Gene By Gene Ltd.
  • 31.14. Dante Labs Inc.
  • 31.15. 23mofang Co. Ltd.

32. Global Hereditary Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hereditary Testing Market

34. Recent Developments In The Hereditary Testing Market

35. Hereditary Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Hereditary Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Hereditary Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Hereditary Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer